HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Correspondence: Submit a response Alert me when this article is cited Alert me when Correspondence are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Goetz, C. G. Articles by Shannon, K. M. Search for Related Content PubMed PubMed Citation Articles by Goetz, C. G. Articles by Shannon, K. M.

A rating scale for Gilles de la Tourette's syndrome

Description, reliability, and validity data

Departments of Neurological Sciences (Drs. Goetz, Tanner, and Shannon) and Neuropsychology (Dr. Wilson), Rush-Presbyterian St. Luke's Medical Center, Chicago, IL.

We developed a rating scale for tic disorders that uses only objective criteria and accommodates the variety of tic manifestations. Using short videotaped recordings with the examiner out of the taping room, we measured five tic variables: number of body areas affected, frequency of motor tics and vocalizations, and severity of motor tics and vocalizations. The rating scale fulfilled tests for inter-rater reliability and temporal stability, and correlated well with scales used to assess global changes over prolonged periods. It objectively detected improvement in tics with neuroleptics, the one pharmacotherapy accepted to abate tics in most patients.

Address correspondence and reprint requests to Dr. Goetz, Department of Neurological Sciences, Rush-Presbyterian St. Luke's Medical Center, 1725 West Harrison Street, Chicago, IL 60612.

Received October 13, 1986. Accepted for publication in final form December 16, 1986.

This article has been cited by other articles:

				J S Stern, S Burza, and M M Robertson Gilles de la Tourette's syndrome and its impact in the UK Postgrad. Med. J., January 1, 2005; 81(951): 12 - 19. [Abstract] [Full Text] [PDF]

				E. J. Pappert, C. G. Goetz, E. D. Louis, L. Blasucci, and S. Leurgans Objective assessments of longitudinal outcome in Gilles de la Tourette's syndrome Neurology, October 14, 2003; 61(7): 936 - 940. [Abstract] [Full Text] [PDF]

				R.L. Albin, R.A. Koeppe, N.I. Bohnen, T.E. Nichols, P. Meyer, K. Wernette, S. Minoshima, M.R. Kilbourn, and K.A. Frey Increased ventral striatal monoaminergic innervation in Tourette syndrome Neurology, August 12, 2003; 61(3): 310 - 315. [Abstract] [Full Text] [PDF]

				T B Babel, P C Warnke, and C B Ostertag Immediate and long term outcome after infrathalamic and thalamic lesioning for intractable Tourette's syndrome J. Neurol. Neurosurg. Psychiatry, May 1, 2001; 70(5): 666 - 671. [Abstract] [Full Text] [PDF]

				C. Marras, D. Andrews, E. Sime, and A. E. Lang Botulinum toxin for simple motor tics: A randomized, double-blind, controlled clinical trial Neurology, March 13, 2001; 56(5): 605 - 610. [Abstract] [Full Text] [PDF]

				S. Chouinard and B. Ford Adult onset tic disorders J. Neurol. Neurosurg. Psychiatry, June 1, 2000; 68(6): 738 - 743. [Abstract] [Full Text] [PDF]

				P. Meyer, N. I. Bohnen, S. Minoshima, R. A. Koeppe, K. Wernette, M. R. Kilbourn, D. E. Kuhl, K. A. Frey, and R. L. Albin Striatal presynaptic monoaminergic vesicles are not increased in Tourette's syndrome Neurology, July 1, 1999; 53(2): 371 - 371. [Abstract] [Full Text] [PDF]